RESUMO
PURPOSE: Body image is a multidimensional construct that encompasses perceptions about body size, emotions, and cognition about physical appearance. Obese identity is related to body image in the lifetime, and according to scientific literature body image dissatisfaction among obese patient persist after bariatric surgery. The objective of this review is to examine the body image changes in patients with obesity pre-and post-bariatric surgery. METHODS: We have carried out a systematic review of literature on PubMed. Initially, 169 publications have been identified, but in total, in compliance with inclusion and exclusion criteria, 15 studies have been analyzed. RESULTS: According to the examined literature, body image does not change after bariatric surgery. These patients will be difficult to adapt for a new body, because there is a persistent obese view of self. Furthermore, ex-obese patients are dissatisfied with the excessive skin after bariatric surgery. Excessive body weight, and negative self-image are replaced with dissatisfaction with excessive skin, and the factors associated with body image stability are still unknown. CONCLUSION: Literature examination raises the issue of body image dissatisfaction, but does not explain why it varies so widely across bariatric patients. Obese identity is related to body image across the lifetime and is an important factor of post-surgical outcomes. Longitudinal studies based on ideal body image pre- and post- bariatric surgery and evidence-based controlled studies on psychotherapeutic treatment for body image dissatisfaction are strongly recommended. Psychotherapy could improve body image quality and wellbeing. LEVEL I: Evidence obtained from: systematic reviews of experimental studies.
Assuntos
Cirurgia Bariátrica , Obesidade Mórbida , Cirurgia Bariátrica/psicologia , Imagem Corporal/psicologia , Humanos , Obesidade/psicologia , Obesidade/cirurgia , Obesidade Mórbida/cirurgia , Autoimagem , Redução de PesoRESUMO
BACKGROUND: First described in 1955, night eating syndrome refers to an abnormal eating behavior clinically defined by the presence of evening hyperphagia (>25% of daily caloric intake) and/or nocturnal awaking with food ingestion occurring ⩾ 2 times per week. AIMS: Although the syndrome is frequently comorbid with obesity, metabolic and psychiatric disorders, its etiopathogenesis, diagnosis, assessment and treatment still remain not fully understood. METHODS: This review was conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines; PubMed database was searched until 31 October 2020, using the key terms: 'Night Eating Syndrome' AND 'complications' OR 'diagnosis' OR 'drug therapy' OR 'epidemiology' OR 'etiology' OR 'physiology' OR 'physiopathology' OR 'psychology' OR 'therapy'. RESULTS: From a total of 239 citations, 120 studies assessing night eating syndrome met the inclusion criteria to be included in the review. CONCLUSION: The inclusion of night eating syndrome into the Diagnostic and Statistical Manual of Mental Disorders-5 'Other Specified Feeding or Eating Disorders' category should drive the attention of clinician and researchers toward this syndrome that is still defined by evolving diagnostic criteria. The correct identification and assessment of NES could facilitate the detection and the diagnosis of this disorder, whose bio-psycho-social roots support its multifactorial nature. The significant rates of comorbid illnesses associated with NES and the overlapping symptoms with other eating disorders require a focused clinical attention. Treatment options for night eating syndrome include both pharmacological (selective serotonin reuptake inhibitors, topiramate and melatonergic drugs) and non-pharmachological approaches; the combination of such strategies within a multidisciplinary approach should be addressed in future, well-sized and long-term studies.
Assuntos
Transtornos da Alimentação e da Ingestão de Alimentos , Síndrome do Comer Noturno , Manual Diagnóstico e Estatístico de Transtornos Mentais , Comportamento Alimentar/psicologia , Transtornos da Alimentação e da Ingestão de Alimentos/diagnóstico , Transtornos da Alimentação e da Ingestão de Alimentos/epidemiologia , Humanos , Hiperfagia/diagnóstico , Hiperfagia/epidemiologia , Hiperfagia/psicologia , Síndrome do Comer Noturno/epidemiologia , Síndrome do Comer Noturno/psicologia , Obesidade/psicologiaRESUMO
The main purpose of this study is to describe how negative emotions were investigated in the sphere of dermatological diseases, in order (1) to summarize literature trends about skin disorders and emotions, (2) to highlight any imbalances between the most studied and neglected emotions, (3) and to offer directions for future research. A computerized literature search provided 41 relevant and potentially eligible studies. Results showed that the study of emotions in skin disease is limited to Sadness/depression and Fear/anxiety. The emotions of Anger and Disgust have been poorly explored in empirical studies, despite they could be theoretically considered a vulnerability factor for the development of skin disorders and the dermatological extreme consequences, as negative emotionality toward self and the pathological skin condition. The bibliometric qualitative analysis with VOSViewer software revealed that the majority of the studies have been focused on the relationships between vitiligo and Sadness/depression, dermatitis and Fear/anxiety, psoriasis, and Anger, suggesting the need of future research exploring Disgust and, in general, a wider emotional spectrum.
El objetivo principal de este estudio fue describir cómo se han investigado las emociones negativas en el ámbito de las enfermedades dermatológicas, con el fin de (1) resumir las tendencias de la literatura sobre las enfermedades de la piel y las emociones, (2) para resaltar las diferencias entre las emociones más estudiados y las más descuidadas y (3) ofrecer direcciones para futuras investigaciones. Una búsqueda bibliográfica computarizada proporcionó 41 estudios relevantes y potencialmente elegibles. Los resultados mostraron que el estudio de las emociones en la enfermedad de la piel se limita a Tristeza/depresión y Miedo/ansiedad. Las emociones de la ira y el asco han sido poco exploradas en estudios empíricos, a pesar de que teóricamente podrían considerarse un factor de vulnerabilidad para el desarrollo de enfermedades de la piel y las consecuencias dermatológicas extremas, como la emocionalidad negativa hacia uno mismo y la condición patológica de la piel. El análisis cualitativo bibliométrico con el software VOSViewer reveló que la mayoría de los estudios se han centrado en las relaciones entre vitiligo y Tristeza/depresión, dermatitis y Miedo/ansiedad, psoriasis e Ira, lo que sugiere la necesidad de futuras investigaciones que exploren asco y, en general, un espectro emocional más amplio.
RESUMO
The use of cannabis among college students is increasing. Cannabis abuse has been proposed to be associated with personality dimensions. However, there are currently no known studies on the relationship of temperament traits and recreational cannabis use among college students. This is a cross-sectional study that investigated 328 students at a Podiatric Medical College. We evaluated the association between temperament and recreational cannabis use by the students. Temperament was investigated using the Memphis, Pisa, Paris and San Diego Auto- Questionnaire (TEMPS-A (short version)). Additionally, we assessed demographics variables and perceived stress in the context of cannabis use, and analyzed the findings using logistic regression. The prevalence of recreational cannabis use was 8.45%. Recreational cannabis use among these students was highly associated with irritable and cyclothymic temperament traits. There was no association between recreational cannabis use and perceived stress, and demographic variables or other substance use. Furthermore, logistic regression analysis indicated that higher scores in cyclothymic or irritable temperament traits are significant predictors for recreational cannabis use. Our study has identified key temperament traits, with a strong association with recreational use of cannabis of the studied student population. Our findings are useful in designing screening and educational strategies directed towards increasing the wellbeing of medical students.
Assuntos
Cannabis , Fumar Maconha , Estudantes de Medicina , Temperamento , Adulto , Estudos Transversais , Feminino , Humanos , Masculino , Inventário de Personalidade , Reprodutibilidade dos Testes , Estudantes de Medicina/psicologia , Inquéritos e Questionários , Adulto JovemRESUMO
Introduzione. La frazione polifenolica del bergamotto (BPF) ha dimostrato di possedere buona efficacia nel trattamento dei pazienti affetti da sindrome metabolica (SM) e pertanto potrebbe rappresentare una strategia promettente nel trattamento degli effetti collaterali indotti da antipsicotici di seconda generazione (SGA) in soggetti schizofrenici in trattamento con tali farmaci. Materiali e metodi. A 15 pazienti schizofrenici in trattamento stabilizzato con SGA e 15 soggetti di controllo non affetti da patologie psichiatriche, che presentavano valori ematici di colesterolo totale compresi tra 200 e 239 mg/dl, è stato somministrato un integratore contenente BPF (1000 mg) per un periodo di 60 giorni. A tutti i soggetti all'inizio e alla fine del trattamento sono state eseguite la misurazione dell'indice di massa corporea (BMI) e una serie di esami ematochimici per la valutazione degli aspetti metabolici (colesterolo totale, LDL, HDL, trigliceridi, glicemia). Risultati. In entrambi i gruppi si è evidenziata una riduzione significativa del BMI (BMI T0 vs Tfinale (media±DS)= schizofrenici: 34,5±5,7 vs 33,9±5,4, p=,041; controlli: 28,1±4,5 vs 27,3±4,1, p=,016 - BMIcambiamento schizofrenici vs controlli (media±DS)= -0,59±0.7 vs -0,72±0,8, p=,378); colesterolo totale e LDL risultano invece essere diminuiti esclusivamente nel gruppo di controllo (colesterolo totalecambiamento schizofrenici vs controlli (media±DS)= 8,2±31,5 vs -35,1±31,1, p=,003; LDLcambiamento schizofrenici vs controlli (media±DS)= 14,1±29,4 vs -9±38,9, p=,014). Discussione. La differenza di efficacia dei BPF sulla dislipidemia tra i soggetti schizofrenici e il gruppo di controllo potrebbe essere spiegata dai diversi meccanismi patogenetici che sono alla base delle alterazioni metaboliche nei soggetti in trattamento con SGA e nei pazienti che non assumono questa classe di farmaci. Conclusioni. Ulteriori studi si rendono necessari al fine di valutare in questa categoria di soggetti i possibili effetti sulla dislipidemia di dosi maggiori di BPF.
Assuntos
Citrus , Síndrome Metabólica/tratamento farmacológico , Fitoterapia , Extratos Vegetais/uso terapêutico , Antipsicóticos/uso terapêutico , Fracionamento Químico , Feminino , Humanos , Masculino , Síndrome Metabólica/etiologia , Pessoa de Meia-Idade , Projetos Piloto , Polifenóis , Esquizofrenia/complicações , Esquizofrenia/tratamento farmacológicoRESUMO
BACKGROUND: Novel treatment strategies for cognitive dysfunctions may prevent long-term disability in patients with schizophrenia, and polyphenolic compounds might be a promising strategy. Bergamot (Citrus bergamia), a citrus fruit characterized by a high amount of flavonoids and flavonoid glycosides, may represent a potential nutraceutical approach to cognitive dysfunction. The present study was aimed to explore the efficacy of bergamot polyphenolic fraction (BPF) supplementation on cognitive/executive functioning in a sample of patients with schizophrenia receiving second-generation antipsychotics. METHODS: Twenty outpatients treated with second-generation antipsychotics assumed BPF at an oral daily dose of 1000 mg/d for 8 weeks. Brief Psychiatric Rating Scale, Wisconsin Card Sorting Test (WCST), Verbal Fluency Task-Controlled Oral Word Association Test, and Stroop Color-Word Test were administered. RESULTS: At end point, (week 8) BPF supplementation significantly improved WCST "perseverative errors" (P = 0.004) and semantic fluency test (P = 0.004). Moreover, a trend for other cognitive variable (WCST "categories," phonemic fluency, and Stroop Color-Word Test) improvement was observed. CONCLUSIONS: The findings provide evidence that BPF administration may be proposed as a potential supplementation strategy to improve cognitive outcome in schizophrenia. Further clinical trials with adequately powered and well-designed methodology are needed to better explore the BPF effectiveness on cognitive impairments in patients with schizophrenia.
Assuntos
Antipsicóticos/administração & dosagem , Cognição/efeitos dos fármacos , Óleos de Plantas/administração & dosagem , Polifenóis/administração & dosagem , Esquizofrenia/diagnóstico , Esquizofrenia/tratamento farmacológico , Administração Oral , Adulto , Cognição/fisiologia , Quimioterapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Fatores de Tempo , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: In this study, we examined the impact of personality traits, assessed with the psychopathic personality inventory revised version (PPI-R), on medical students' likelihood of selecting a surgical specialty. METHODS: This is a cross-sectional questionnaire-based study of 360 4th-year medical students at a single university. We used the PPI-R previously developed to evaluate "adaptive" traits within nonclinical (student) populations. Students were asked to express their specialty of choice. Medical specialties were categorized as surgical and nonsurgical. Logistic regression was used to identify predictors and appropriate adjustments were made for demographic factors. RESULTS: The survey was completed by 335 out of 360 students. The prevalence of students aspiring to a surgical career was 23.6%. They exhibited higher PPI-R total score, self-centered impulsivity (SCI) factor score, Machiavellian egocentricity, social influence, and fearlessness content scale scores. Logistic regression showed that SCI score was a significant predictor for the likelihood of expressing interest toward a surgical career. DISCUSSION: Our findings expand previous research on the usefulness of the nonclinical use of psychopathic personality traits to investigate career choice.
Assuntos
Personalidade , Especialização , Estudantes de Medicina/psicologia , Cirurgiões/psicologia , Adulto , Transtorno da Personalidade Antissocial/psicologia , Escolha da Profissão , Estudos Transversais , Feminino , Humanos , Itália , Masculino , Inquéritos e QuestionáriosRESUMO
Panic disorder (PD) is a disabling anxiety disorder that is characterized by unexpected, recurrent panic attacks, associated with fear of dying and worrying about possible future attacks or other behavioral changes as a consequence of the attacks. The acid-sensing ion channels (ASICs) are a family of proton-sensing channels expressed throughout the nervous system. Their activity is linked to a variety of behaviors including fear, anxiety, pain, depression, learning, and memory. The human analog of ASIC1a is the amiloride-sensitive cation channel 2 (ACCN2). Adenosine A2A receptors are suggested to play an important role in different brain circuits and pathways involved in anxiety reactions. In this work we aimed to evaluate the distribution of ACCN2 rs685012 and ADORA2A rs2298383 polymorphisms in PD patients compared with healthy subjects. We found no association between ADORA2A polymorphism and PD. Instead, the C mutated allele for ACCN2 rs685012 polymorphism was significantly more frequent in patients than in controls. On the contrary, the TT homozygous wild-type genotype and also the ACCN2 TT/ADORA2A CT diplotype were significantly more represented in controls. These results are suggestive for a role of ACCN2 rs685012 polymorphism in PD development in Caucasian people.
Assuntos
Canais Iônicos Sensíveis a Ácido/genética , Transtorno de Pânico/genética , Polimorfismo de Nucleotídeo Único , Receptor A2A de Adenosina/genética , Canais Iônicos Sensíveis a Ácido/fisiologia , Adulto , Alelos , Animais , Química Encefálica , Estudos de Casos e Controles , Feminino , Genótipo , Humanos , Masculino , Camundongos , Pessoa de Meia-Idade , Receptor A2A de Adenosina/fisiologia , Sicília , Especificidade da Espécie , População Branca/genética , Adulto JovemRESUMO
OBJECTIVE: The present study was aimed to investigate quality of life, negative emotions, such as anger, anxiety and depression, and possible psychopathological comorbidity in patients affected by endometriosis. STUDY DESIGN: We undertook a prospective, cohort study between October 2013 and February 2014. We selected patients with histologically confirmed ovarian endometriosis (Endometriosis Group) and with other benign adnexal diseases (Control Group) who underwent laparoscopic surgery. Participants underwent a psychometric assessment using the following self-report instruments: Symptom Checklist-90-R, State-Trait Anger Expression Inventory-2, Self-Rating Anxiety Scale, Self-Rating Depression Scale, Quality of Life Index. RESULTS: The Endometriosis Group was formed by 166 patients (mean age: 36±6 yrs) matched with 48 controls (mean age: 38.4±12.8 yrs). Somatization (p=0.02), depression (p=0.01), sensitivity (p=0.04) and phobic anxiety (p=0.04) were higher in Endometriosis Group than in Control Group. Endometriosis Group was further characterized by significantly higher levels of anxiety than Control Group (p=0.03) as assessed by Self-Rating Anxiety Scale. Regarding Quality of Life Index, a significant health decline in Endometriosis Group compared with Control Group (p=0.008) was found. CONCLUSION: Higher levels of somatization, depression, sensitivity and anxiety were found in Endometriosis Group compared with Control Group.
Assuntos
Endometriose/psicologia , Adulto , Ansiedade/etiologia , Estudos de Coortes , Comorbidade , Depressão/etiologia , Feminino , Humanos , Pessoa de Meia-Idade , Estudos Prospectivos , Qualidade de Vida , Transtornos Somatoformes/etiologiaRESUMO
BACKGROUND: The State-Trait Anger Expression Inventory 2 (STAXI-2) is a psychometric instrument measuring anger experience and expression. Associations between the STAXI-2 and risk of breast cancer (BC) are rarely considered together in a prospective study. PATIENTS AND METHODS: A total of 117 women with breast symptoms referred for breast examination were selected and assessed before any diagnostic procedures. RESULTS: Twenty-four patients with BC, 44 with benign breast disease (BBD) and 49 healthy individuals (HHS) were included. Scores for parameters state anger/feel like expressing anger physically (SANGP) were significantly higher in the HHS group (HHS vs. BBD: p=0.027; HHS vs. BC: p=0.025). BC patients showed a trend to lower scores in almost all scales of STAXI-2, except for the scales trait anger/angry temperament (TANGT), anger expression-in (AX-I), and anger control-out (AC-O), that were higher than the two other groups' scores. CONCLUSION: The results of this study do not support a specific link between STAXI-2 and breast cancer risk.